NCT05438004

Brief Summary

In 2016, according to the national perinatal survey, the average length of stay in maternity hospitals in France after a vaginal delivery was 4.0 days, confirming the decrease in this length of stay compared with previous surveys, but placing France among the Western countries with the longest stay. Several countries that have further reduced the average length of stay offer low-risk populations a return home in the first few hours after delivery. As early as 2014, the Haute Autorité de Santé reminded us that "once low risk is defined, the length of stay in the maternity hospital is not discriminating for the safety of the mother and the newborn. The optimal length of stay would rather depend on the organization of the discharge from the maternity hospital, the medical follow-up and the subsequent support". The studies against a very early discharge are the result of experiments that do not define low risk, and/or do not propose home support. This pilot study aims to provide a framework for a care pathway allowing discharge from the maternity hospital from the 2nd hour and before the 24th hour following an uncomplicated delivery. Its main objective is to show that such a care pathway allows to respect the French postpartum recommendations, while answering a legitimate expectation of personalization of the care offered to women wishing to be monitored at home earlier after the delivery. It also studies the complications, tolerance, satisfaction and cost of such care. This is a non-randomized cohort study. It studies 100 voluntary mother-newborn couples, after a delivery at the Nice University Hospital, meeting objective criteria of low risk. A daily follow-up is ensured by a liberal midwife during the first 3 days. The link between the patient, the private midwife and the maternity hospital is maintained permanently thanks to a free dedicated mobile application. This application, equipped with an alert system, is an additional guarantee of compliance with the recommendations for screening and mandatory procedures. It allows for a safer transfer of hospital care to ambulatory care, while providing personalized care tailored to the patient's expectations. This pilot study would be the beginning of a larger study demonstrating the non-inferiority of such a care pathway compared to the most common management requiring a stay of several days in a maternity hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 29, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
Last Updated

May 26, 2026

Status Verified

July 1, 2025

Enrollment Period

3.3 years

First QC Date

June 24, 2022

Last Update Submit

May 21, 2026

Conditions

Keywords

AmbulatoryChildbirth

Outcome Measures

Primary Outcomes (1)

  • Emergency visits

    Percentage of emergency visits for neonatal or maternal reasons within one month of delivery

    one month

Secondary Outcomes (5)

  • post partum recommendations

    one month

  • Breastfeading rate

    one month

  • Maternal pain

    Day 2

  • Satisfaction score

    One month

  • Cost of outpatient care

    one month

Study Arms (1)

Ambulatory nice birth

EXPERIMENTAL

Discharge from the maternity ward from the 2nd hour and before the 24th hour following an uncomplicated delivery

Other: Ambulatory nice birth

Interventions

discharge from the maternity ward from the 2nd hour and before the 24th hour following an uncomplicated delivery

Ambulatory nice birth

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Maternal:
  • Voluntary
  • Legal age
  • Vaginal delivery
  • General Health Insurance Plan
  • Accompanying person present at discharge and every day during the first 2 days
  • Pain VAS \< 5 with or without simple analgesics
  • Mother-child interaction judged satisfactory by the team
  • Signature of consent
  • Pediatric :
  • Singleton
  • \> 38 weeks of amenorrhea
  • Eutrophic
  • Apgar \> 7 at 5 minutes of life
  • Respiratory rate \< 60/min; 90bpm \< Heart rate \< 170bpm; SaO2 \>95
  • +4 more criteria

You may not qualify if:

  • Maternal:
  • Social isolation, psychiatric disorder with impact on infant care, moderate to severe (according to DSM5) substance use disorder
  • Poorly balanced chronic condition requiring hospitalization
  • Postpartum complications requiring hospitalization
  • Postpartum hemorrhage \> 500mL
  • Body temperature \> 38.0°C without paracetamol
  • Thromboembolic signs: pain, edema, positive Homans sign
  • Protected persons defined in the following articles of the public health code:
  • L. 1121-6: persons deprived of liberty by a judicial or administrative decision, persons hospitalized without consent and persons admitted to a health or social institution for purposes other than research; L. 1121-8: adults subject to a legal protection measure or unable to express their consent; L. 1122-1-2: persons in emergency situations unable to give prior consent.
  • Pediatric :
  • Jaundice
  • Risk factor for neonatal infection (maternal streptococcal B colonization during the current pregnancy, history of neonatal streptococcal B infection in a previous pregnancy, duration of rupture of membranes \> 12 hours, maternal temperature \> 38.0°C intrapartum or during the 2 hours following delivery).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Archet

Nice, France

Location

Related Publications (1)

  • Gauci PA, Adrados C, Albouy C, Roy M, Walrave Y, Marioli S, Benamer L, Delotte J. Implementation of early postnatal discharge within 24 h in France: Safety, satisfaction, and feasibility trial supported by a connected home monitoring application (NICE-BIRTH study). Women Birth. 2026 Apr 24;39(3):102205. doi: 10.1016/j.wombi.2026.102205. Online ahead of print.

Study Officials

  • Pierre-Alexis GAUCI, MD-PHD

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2022

First Posted

June 29, 2022

Study Start

December 19, 2021

Primary Completion

March 20, 2025

Study Completion

March 20, 2025

Last Updated

May 26, 2026

Record last verified: 2025-07

Locations